The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial.

Saved in:
Bibliographic Details
Title: The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial.
Authors: Keating, S, Suciu, S, de Witte, T, Zittoun, R, Mandelli, F, Belhabri, A, Amadori, S, Fibbe, W, Gallo, E, Fillet, G, Varet, B, Meloni, G, Hagemeijer, A, Fazi, P, Solbu, G, Willemze, R
Source: Leukemia (08876924). Jan2003, Vol. 17 Issue 1, p60. 8p.
Database: Academic Search Ultimate
Description
ISSN:08876924